BioStem made the announcement on November 20, 2024. The company indicated that the acquisition of revyve antimicrobial wound gel reflects BioStem’s continued commitment to building a diverse portfolio ...
BioStem made the announcement on November 20, 2024. The company indicated that the acquisition of revyve TM Antimicrobial Wound Gel reflects BioStem’s continued commitment to building a diverse ...
WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech” or “Kane”) announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results